For: |
Zhang GM, Yang Y, Huang B, Xiao H, Li D, Feng ZH. Experimental study on therapeutic effect of |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v9/i9/1940.htm |
Number | Citing Articles |
1 |
Wei Gong, Yi Liu, Bo Huang, Zhang Lei, Feng-Hua Wu, Dong Li, Zuo-Hua Feng, Gui-Mei Zhang. Recombinant CBD–HepII polypeptide of fibronectin inhibits αvβ3 signaling and hematogenous metastasis of tumor. Biochemical and Biophysical Research Communications 2008; 367(1): 144 doi: 10.1016/j.bbrc.2007.12.110
|
2 |
Jia Wei, Yiquan Xiong. Inhibitory effect of recombinant fibronectin polypeptide CH50 on invasion and metastasis of melanoma B16 cells. Journal of Huazhong University of Science and Technology 2007; 27(1): 17 doi: 10.1007/s11596-007-0105-2
|
3 |
Yi Liu, Bo Huang, Ye Yuan, Wei Gong, Han Xiao, Dong Li, Zhi‐Rui Yu, Feng‐Hua Wu, Gui‐Mei Zhang, Zuo‐Hua Feng. Inhibition of hepatocarcinoma and tumor metastasis to liver by gene therapy with recombinant CBD‐HepII polypeptide of fibronectin. International Journal of Cancer 2007; 121(1): 184 doi: 10.1002/ijc.22644
|
4 |
Yanhua Wu, Xiaojing Qiao, Shouyi Qiao, Long Yu. Targeting integrins in hepatocellular carcinoma. Expert Opinion on Therapeutic Targets 2011; 15(4): 421 doi: 10.1517/14728222.2011.555402
|
5 |
Mingcai Li, Zuohua Feng, Guimei Zhang, Dong Li. High-level expression of a recombinant fragment of human fibronectin containing the Cell I–Hep II–IIICS71 domain in Escherichia coli as a soluble protein. Biotechnology Letters 2006; 28(14): 1141 doi: 10.1007/s10529-006-9066-y
|